Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.

@article{Jongh1992SurvivalAP,
  title={Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.},
  author={Felix E. de Jongh and Harry L. A. Janssen and Robert A de Man and Wim C. J. Hop and Solko W. Schalm and Mark van Blankenstein},
  journal={Gastroenterology},
  year={1992},
  volume={103 5},
  pages={1630-5}
}
To evaluate indications for new therapies such as liver transplantation and antiviral therapy, survival of histologically proven hepatitis B surface antigen (HBsAg)-positive cirrhosis of the liver was assessed in a cohort of 98 patients followed up for a mean of 4.3 years. The overall survival probability was 92% at 1 year, 79% at 3 years, and 71% at 5 years. Variables significantly associated with the duration of survival were age, serum aspartate aminotransferase levels, presence of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 116 extracted citations

Treatment of Hepatitis B in Decompensated Liver Cirrhosis

International journal of hepatology • 2011
View 5 Excerpts
Highly Influenced

Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.

Liver international : official journal of the International Association for the Study of the Liver • 2010
View 4 Excerpts
Highly Influenced

Natural history of hepatitis B.

Journal of hepatology • 2003
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…